HomeCompareFSPKF vs MRK

FSPKF vs MRK: Dividend Comparison 2026

FSPKF yields 1.53% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $23.1K in total portfolio value
10 years
FSPKF
FSPKF
● Live price
1.53%
Share price
$23.02
Annual div
$0.35
5Y div CAGR
31.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.6K
Annual income
$3,544.59
Full FSPKF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FSPKF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSPKFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSPKF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSPKF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSPKF
Annual income on $10K today (after 15% tax)
$130.35/yr
After 10yr DRIP, annual income (after tax)
$3,012.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $5,315.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSPKF + MRK for your $10,000?

FSPKF: 50%MRK: 50%
100% MRK50/50100% FSPKF
Portfolio after 10yr
$45.2K
Annual income
$6,671.37/yr
Blended yield
14.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FSPKF
No analyst data
Price Target
$23.65
+2.7% upside vs current
Range: $21.30 — $26.00
Altman Z
26.1
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSPKF buys
0
MRK buys
0
No recent congressional trades found for FSPKF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSPKFMRK
Forward yield1.53%2.76%
Annual dividend / share$0.35$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.2%32.7%
Portfolio after 10y$33.6K$56.8K
Annual income after 10y$3,544.59$9,798.13
Total dividends collected$11.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$23.65$128.54

Year-by-year: FSPKF vs MRK ($10,000, DRIP)

YearFSPKF PortfolioFSPKF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,901$201.19$11,206$366.19$305.00MRK
2$11,933$268.93$12,650$502.35$717.00MRK
3$13,130$360.97$14,407$694.19$1.3KMRK
4$14,536$486.98$16,585$967.82$2.0KMRK
5$16,214$661.07$19,342$1,363.89$3.1KMRK
6$18,253$904.19$22,913$1,947.19$4.7KMRK
7$20,779$1,248.12$27,662$2,823.89$6.9KMRK
8$23,976$1,742.18$34,159$4,173.35$10.2KMRK
9$28,119$2,464.85$43,337$6,308.80$15.2KMRK
10$33,632$3,544.59$56,776$9,798.13$23.1KMRK

FSPKF vs MRK: Complete Analysis 2026

FSPKFStock

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Full FSPKF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FSPKF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSPKF vs SCHDFSPKF vs JEPIFSPKF vs OFSPKF vs KOFSPKF vs MAINFSPKF vs JNJFSPKF vs ABBVFSPKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.